198 related articles for article (PubMed ID: 24760272)
1. Influence of peripheral whole-blood microRNA-7 and microRNA-221 high expression levels on the acquisition of castration-resistant prostate cancer: evidences from in vitro and in vivo studies.
Santos JI; Teixeira AL; Dias F; Maurício J; Lobo F; Morais A; Medeiros R
Tumour Biol; 2014 Jul; 35(7):7105-13. PubMed ID: 24760272
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of miR-3195, miR-3687 and miR-4417 is associated with castration-resistant prostate cancer.
Rönnau CGH; Fussek S; Smit FP; Aalders TW; van Hooij O; Pinto PMC; Burchardt M; Schalken JA; Verhaegh GW
World J Urol; 2021 Oct; 39(10):3789-3797. PubMed ID: 33990872
[TBL] [Abstract][Full Text] [Related]
3. Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer.
Huang X; Yuan T; Liang M; Du M; Xia S; Dittmar R; Wang D; See W; Costello BA; Quevedo F; Tan W; Nandy D; Bevan GH; Longenbach S; Sun Z; Lu Y; Wang T; Thibodeau SN; Boardman L; Kohli M; Wang L
Eur Urol; 2015 Jan; 67(1):33-41. PubMed ID: 25129854
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker.
Goto Y; Kojima S; Nishikawa R; Kurozumi A; Kato M; Enokida H; Matsushita R; Yamazaki K; Ishida Y; Nakagawa M; Naya Y; Ichikawa T; Seki N
Br J Cancer; 2015 Sep; 113(7):1055-65. PubMed ID: 26325107
[TBL] [Abstract][Full Text] [Related]
5. Functional roles of miR-625-5p and miR-874-3p in the progression of castration resistant prostate cancer.
Aktan Ç; Çal Ç; Kaymaz B; Selvi Günel N; Kıpçak S; Özel B; Gündüz C; Şahin Küçükaslan A; Aygüneş Jafari D; Kosova B
Life Sci; 2022 Jul; 301():120603. PubMed ID: 35508255
[TBL] [Abstract][Full Text] [Related]
6. Functional roles and potential clinical application of miRNA-345-5p in prostate cancer.
Tinay I; Tan M; Gui B; Werner L; Kibel AS; Jia L
Prostate; 2018 Sep; 78(12):927-937. PubMed ID: 29748958
[TBL] [Abstract][Full Text] [Related]
7. Significant Association of Caveolin-1 and Caveolin-2 with Prostate Cancer Progression.
Sugie S; Mukai S; Yamasaki K; Kamibeppu T; Tsukino H; Kamoto T
Cancer Genomics Proteomics; 2015; 12(6):391-6. PubMed ID: 26543085
[TBL] [Abstract][Full Text] [Related]
8. Pirin: a potential novel therapeutic target for castration-resistant prostate cancer regulated by miR-455-5p.
Arai T; Kojima S; Yamada Y; Sugawara S; Kato M; Yamazaki K; Naya Y; Ichikawa T; Seki N
Mol Oncol; 2019 Feb; 13(2):322-337. PubMed ID: 30444038
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis.
Barros-Silva D; Costa-Pinheiro P; Duarte H; Sousa EJ; Evangelista AF; Graça I; Carneiro I; Martins AT; Oliveira J; Carvalho AL; Marques MM; Henrique R; Jerónimo C
Cell Death Dis; 2018 Feb; 9(2):167. PubMed ID: 29415999
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-23b and microRNA-27b plus flutamide treatment enhances apoptosis rate and decreases CCNG1 expression in a castration-resistant prostate cancer cell line.
Pimenta RC; Viana NI; Amaral GQ; Park R; Morais DR; Pontes J; Guimaraes VR; Camargo JA; Leite KR; Nahas WC; Srougi M; Reis ST
Tumour Biol; 2018 Nov; 40(11):1010428318803011. PubMed ID: 30400755
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA expression profile of primary prostate cancer stem cells as a source of biomarkers and therapeutic targets.
Rane JK; Scaravilli M; Ylipää A; Pellacani D; Mann VM; Simms MS; Nykter M; Collins AT; Visakorpi T; Maitland NJ
Eur Urol; 2015 Jan; 67(1):7-10. PubMed ID: 25234358
[TBL] [Abstract][Full Text] [Related]
12. Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer.
Nguyen HC; Xie W; Yang M; Hsieh CL; Drouin S; Lee GS; Kantoff PW
Prostate; 2013 Mar; 73(4):346-54. PubMed ID: 22887127
[TBL] [Abstract][Full Text] [Related]
13. MiR-1247-5p is overexpressed in castration resistant prostate cancer and targets MYCBP2.
Scaravilli M; Porkka KP; Brofeldt A; Annala M; Tammela TL; Jenster GW; Nykter M; Visakorpi T
Prostate; 2015 Jun; 75(8):798-805. PubMed ID: 25731699
[TBL] [Abstract][Full Text] [Related]
14. GR silencing impedes the progression of castration-resistant prostate cancer through the JAG1/NOTCH2 pathway via up-regulation of microRNA-143-3p.
Zhang L; Jiang H; Zhang Y; Wang C; Xia X; Sun Y
Cancer Biomark; 2020; 28(4):483-497. PubMed ID: 32568179
[TBL] [Abstract][Full Text] [Related]
15. Impact of novel miR-145-3p regulatory networks on survival in patients with castration-resistant prostate cancer.
Goto Y; Kurozumi A; Arai T; Nohata N; Kojima S; Okato A; Kato M; Yamazaki K; Ishida Y; Naya Y; Ichikawa T; Seki N
Br J Cancer; 2017 Jul; 117(3):409-420. PubMed ID: 28641312
[TBL] [Abstract][Full Text] [Related]
16. miR-663 induces castration-resistant prostate cancer transformation and predicts clinical recurrence.
Jiao L; Deng Z; Xu C; Yu Y; Li Y; Yang C; Chen J; Liu Z; Huang G; Li LC; Sun Y
J Cell Physiol; 2014 Jul; 229(7):834-44. PubMed ID: 24243035
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Novel Liquid Biomarkers in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide: A Prospective Observational Study.
Benoist GE; van Oort IM; Boerrigter E; Verhaegh GW; van Hooij O; Groen L; Smit F; de Mol P; Hamberg P; Dezentjé VO; Mehra N; Gerritsen W; Somford DM; van Erp NPH; Schalken JA
Clin Chem; 2020 Jun; 66(6):842-851. PubMed ID: 32408351
[TBL] [Abstract][Full Text] [Related]
18. Screening key microRNAs for castration-resistant prostate cancer based on miRNA/mRNA functional synergistic network.
Zhu J; Wang S; Zhang W; Qiu J; Shan Y; Yang D; Shen B
Oncotarget; 2015 Dec; 6(41):43819-30. PubMed ID: 26540468
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-200a suppresses prostate cancer progression through BRD4/AR signaling pathway.
Guan H; You Z; Wang C; Fang F; Peng R; Mao L; Xu B; Chen M
Cancer Med; 2019 Apr; 8(4):1474-1485. PubMed ID: 30784214
[TBL] [Abstract][Full Text] [Related]
20. Activin A regulates microRNAs and gene expression in LNCaP cells.
Ottley EC; Nicholson HD; Gold EJ
Prostate; 2016 Aug; 76(11):951-63. PubMed ID: 27018851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]